01-08-2024 09:39 AM | Source: ARETE Securities Ltd
The markets are expected to open marginally higher today as trends in GIFT Nifty indicate a positive start - ARETE Securities Ltd

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

The markets are expected to open marginally higher today as trends in GIFT Nifty indicate a positive start for the broader index after Nifty closed 93 points higher at 24,951 on Wednesday.

 

Aegis Logistics:

The company announced Project Gati, a capital investment program of INR 4,500 crore under a joint business plan with JV partner Royal Vopak, to be implemented from 2023-2027.

Autoline Industries:

The company has entered into a contract with Tata Motors Passenger Vehicle Limited for the manufacturing tools and supply of sheet metal parts and assemblies, valued at INR 204 crore.

Barbeque-Nation Hospitality:

The company will further acquire a 4.14% stake in Red Apple Kitchen Consultancy for INR 100.2M.

Capri Global Capital:

The company will consider raising funds up to INR 20B.

Coal India:

The company reported Q1 EBITDA of INR 144.24B, up 6.4% YoY, with an EBITDA margin of 39.56% vs. 37.66% YoY; Q1 revenue of INR 364.65B, up 1.3% YoY, and Q1 consolidated net profit of INR 109.59B, up 4.1% YoY and 26.2% QoQ.

Eimco Elecon:

The company has won an order worth INR 23.18 crore.

GE Power India:

The company has received purchase orders worth INR 38.3 million from Torrent Power and NTPC.

Ind Swift Laboratories:

The company is set to invest INR 400M in debentures of Ashok Investors Trust.

L&T:

The company won a significant contract, valued between INR 10B and 25B.

Sansera Engineering:

The company entered a pact with the Karnataka government for the acquisition of 55 acres of industrial land near Bengaluru.

Tata Steel:

The company has acquired a 26% equity stake in TP Parivart for INR 350 million and will infuse funds up to INR 60 billion in Neelachal Ispat Nigam.

Zydus Life:

The company received approval from COFEPRIS of Mexico to market Mamitra (trastuzumab biosimilar) for the treatment of various cancers.

 

Please refer disclaimer at http://www.aretesecurities.com/

SEBI Regn. No.: INM00001274